HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 21 April 2011

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 22 papers were listed this time. Here's a handful:

Pinto AM, Kuppermann M, Nakagawa S, et al. Comparison and correlates of three preference-based health-related quality-of-life measures among overweight and obese women with urinary incontinence. Qual Life Res. 2011 Apr 3. [Epub ahead of print] PubMed PMID:21461953.

Purmonen TT, Pänkäläinen E, Turunen JH, et al. Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial. Acta Oncol. 2011 Apr;50(3):344-52. Epub 2011 Feb 8. PubMed PMID: 21299447.

Furiak NM, Ascher-Svanum H, Klein RW, et al. Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model. Curr Med Res Opin. 2011 Apr;27(4):713-30. Epub 2011 Jan 25. PubMed PMID: 21265593.

Klersy C, De Silvestri A, Gabutti G, et al. Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure. Eur J Heart Fail. 2011 Apr;13(4):450-9. Epub 2010 Dec 29. PubMed PMID: 21193439.

Anis AH, Bansback N, Sizto S, et al. Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States. J Dermatolog Treat. 2011 Apr;22(2):65-74. Epub 2010 May 5. PubMed PMID: 20443663.